topiramate 25 mg

1. Indications and Usage 1.1 Monotherapy Epilepsy Topiramate tablets are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. 1.2 Adjunctive Therapy Epilepsy Topiramate tablets are indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older. 1.3 Migraine Topiramate tablets are indicated for the preventive treatment of migraine in patients 12 years of age and older.

advanced rx pharmacy of tennessee, llc

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] fatigue` `[4] off label use` `[5] diarrhoea` `[6] dyspnoea` `[7] pain` `[8] headache` `[9] vomiting` `[10] dizziness`

8 months ago

ROUND WHITE C 122

8 months ago

C 122 ROUND WHITE

16. How Supplied/Storage and Handling 16.1 How Supplied

TOPIRAMATE tablets USP

TOPIRAMATE tablets USP are available in the following strengths and colors: 50 mg, Light orange colored, circular, biconvex, film-coated tablets, debossed with "123" on one side and "C" on the other side and are available in Bottles of 30 NDC:80425-0195-01 Bottles of 60 NDC:80425-0195-02 Bottles of 90 NDC:80425-0195-03 PHARMACIST: Dispense in a tight container as defined in the USP. Use child-resistant closure (as required). 16.2 Storage and Handling Store at 20°C to 25°C (68°F to 77°F) [See USP controlled room temperature]. Protect from moisture.

More pills like ROUND C 122

Related Pills

bismuth subsalicylate 262 MG Chewable Tablet

Rugby Laboratories

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site